PRESS RELEASE PRESS RELEASE Paris, 7th November 2024 Q1 results as of September 30, 2024 Unaudited group revenue increased by…
31 October 2024 - Following the positive impact of the mental health services provided to athletes at the Olympic Games Paris 2024,…
TUSTIN, Calif. and LONDON and BOSTON, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the…
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, Nova Scotia, Nov. 06,…
Company announced completed Phase 1 enrollment for SAB-142 with no observation of serum sickness. The company remains on track for…
Conference Call to be held on November 18, 2024, at 5:00 PM EST NEW HAVEN, Conn., Nov. 06, 2024 (GLOBE…
BOSTON, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights…
31 October 2024 - Following the positive impact of the mental health services provided to athletes at the Olympic Games Paris 2024,…
November 05, 2024 20:28 ET | Source: ARCpoint Inc. Greenville, South Carolina, Nov. 05, 2024 (GLOBE NEWSWIRE) -- ARCpoint Inc.…
Tevogen Bio is a fully functional biotech, with investor-valued assets over $10 billion achieved with under $40 million in spending.Approximately…